INTRODUCTION
============

Highly invasive community-acquired strains of *K. pneumoniae* with a particular hypermucoviscous phenotype have been reported as a cause of a distinctive syndrome of community-acquired cryptogenic monomicrobial liver abscess with bacteremia, particularly in Taiwan where this disease is endemic \[[@R1]-[@R10]\]. Although it is still most frequent in Asia where more than 900 cases have been reported, scattered cases are progressively being reported outside of this region \[[@R11]\]. More than one-half of patients with KLAS have diabetes mellitus, whereas the remainder are otherwise healthy individuals \[[@R5],[@R12],[@R13]\]. Septic metastatic complications are frequent \[[@R8],[@R10],[@R14],[@R15]\].

Hypermucoviscous strains of *K. pneumoniae* grow in sticky colonies on agar plates and can be identified by a \"string test\" Fig. (**[1](#F1){ref-type="fig"}**) \[[@R3],[@R10],[@R14]\].

Most of the isolates from patients with KLAS belong to the K1 and to lesser extent K2 serotypes, which are considered to be the most virulent strains of*K. pneumoniae*\[[@R10],[@R16]-[@R20]\]*. MagA*(mucoviscosity-associated gene A) is a chromosomal gene (recently renamed *wzy~KpK1~*) that is required for exopolysaccharide web biosynthesis. This gene, located in the *cps* (capsular polysaccharide synthesis) operon, is specific of K1 serotype \[[@R11],[@R12],[@R21]\], thus is a well-accepted target for the detection of K1 serotype \[[@R18]\]*.* *MagA*-positive (or serotype K1) *K. pneumoniae*is accordingly recognized as the main pathogen of pyogenic liver abscess \[[@R15]\].

The plasmid gene *rmpA* (regulator of mucoid phenotype A) has been shown to be a transcriptional activator of the *wzy~KpK1~ cps* loci, thus enhancing extracapsular polysaccharide synthesis in *K. pneumoniae*\[[@R11]\]. The hypermucoviscous phenotype results from overproduction of extracellular polysaccharides, which is encoded by the chromosome and positively controlled by *rmpA*gene located on a plasmid \[[@R15]\].

Most isolates of serotype K1 *K. pneumoniae* from patients with KLAS in Asia belong to ST23.

The following case illustrates the salient features of KLAS and demonstrates the global spread of this infectious disease into South America.

CASE REPORT
===========

A 55-year-old previously healthy man was admitted with 12 days history of fever and fatigue. He was white, native of Argentina, and denied recent foreign travel, alcohol or drug abuse. He had no significant medical history. He had neither vomiting, nor abdominal spontaneous pain. Clinical examination showed temperature of 40°C and tenderness to percussion over the right upper quadrant of the abdomen. The remainder of the physical examination was unremarkable.

Laboratory tests were remarkable for leukocytosis (41 900 cells/mm^3^), erythrosedimentation rate 73 mm/hour, C reactive protein 372 mg/L, and moderate elevation of alkaline phosphatase and g-glutamyl transpeptidase. HIV serology was negative. Fasting plasma glucose levels were normal.

Abdominal computed tomography (CT) scan with double contrast showed a 15 cm hypodense lesion with internal septa in the liver Fig. (**[2a](#F2a){ref-type="fig"}**), and a hypodense tumour-like lesion with narrowing of the gastric lumen Fig. (**[2b](#F2b){ref-type="fig"}**). The latter was further investigated by endoscopy-ultrasound (EUS), which showed a 3-cm well-circumscribed hypoechoic submucosal mass suggestive of intramural gastric abscess Fig. (**[3a](#F3a){ref-type="fig"}**,**[b](#F3b){ref-type="fig"}**). Chest x-ray, transthoracic echocardiography and abdominal Doppler ultrasound were normal. Blood cultures were taken.

A presumptive diagnosis of liver abscess was made. The patient was started on ceftriaxone plus metronidazole empirically. Sonography-guided percutanous drainage was placed yielding 60 ml of purulent fluid whose Gram stains showed gram-negative bacilli. Histological examination disclosed inflammatory cells and was negative for malignancy. Blood and abscess aerobic cultures yielded a gram-negative lactose-fermenting bacillus identified as*Klebsiella pneumoniae*, whose colonies were particularly sticky. Hypermucoviscous phenotype was confirmed by a positive string test: formation of viscous strings ≥ 5 mm in length when a standard bacteriologic loop was used to stretch the colony on agar plate Fig. (**[1](#F1){ref-type="fig"}**). Antibiotic susceptibility testing was performed by Etest according to Clinical and Laboratory Standards Institute guidelines. The strains were only intrinsically resistant to ampicillin.

Metronidazole was discontinued. Two weeks after admission the patient became afebrile and drainage was removed. The gastric lesion markedly decreased in size during hospitalization. He was discharged on oral ciprofloxacin to complete a 6-week course. A follow-up CT after antibiotic therapy was completed showed resolution of the abscesses. Patient turned to his usual state of health.

Materials and Methodology
-------------------------

Four isolates of *K. pneumoniae* from the patient (2 strains from liver abscess and 2 strains from blood) were sent to the National Health Research Institute of Taiwan for further molecular studies.

Isolates were serotyped using capsule swelling reaction with antisera obtained from Health Protection Agency in UK and by PCR as previously described Table **[1](#T1){ref-type="table"}**. In addition, one tube multiplex PCR for K1, K2 and K5 were performed according to previously published method \[[@R18]\].

Since *magA*, *rmpA* and *aerobactin* are virulent genes associated with KLAS, PCR was used to target these genes. An overnight-cultured bacterial colony was added to 300 μl water and boiled for 15 min to release DNA template. Previously published primers used for PCR were listed in Table **[1](#T1){ref-type="table"}**. The reaction mixture was kept at 95°C for 5 min, followed by 40 temperature cycles of 95°C for1 min, 50°C for 1 min, and 72°C for 2 min, and 72°C for 7 min \[[@R11],[@R14]\].

MLST was performed according to Turton *et al*. \[[@R9]\], to characterize the genotype of the isolates, by determining the nucleotide sequences of seven housekeeping genes (*gapA*, *infB*, *mdh*, *pgi*, *phoE*, *rpoB*, and*tonB*). Sequences of these housekeeping genes were obtained for isolates from liver abscess patients and carriers. Sequences information was compared with those MLST web site (<http://pubmlst.org/kpneumoniae/>) developed by Keith Jolley. Alleles and STs were assigned accordingly. Sequences of any alleles that were not on the database were submitted to the curator and obtained for the allele number. Difference in two or more alleles was considered to be unrelated.

Bacterial DNA was prepared and subjected to PFGE as previously described \[[@R9]\]. The restriction enzyme *Xba*I (New England Biolabs, Beverly, MA, USA) was used at the manufacturer's suggested temperature. Restriction fragments were separated by PFGE in 1% agarose gel (Bio-Rad, Hercules, CA, USA) in 0.5×TBE buffer (45 mmol/L Tris, 45 mmol/L boric acid, 1.0 mmol/L EDTA, pH8.0) for 22 h at 200 V at a temperature of 14^o^C, with ramped times of 2 to 40 s using the Bio-Rad CHEF MAPPER apparatus (Bio-Rad Laboratories, Richmond, CA, USA). Gels were then stained with ethidium bromide and photographed under ultraviolet light. The resulting genomic DNA profiles, or "fingerprints", were interpreted according to established guidelines \[[@R22]\]*.*

Virulence was determined by mouse inoculation: ten mice were used as a sample population for each bacterial concentration. Since all isolates were identical, one isolate was selected for lethal dose causing 50% death (LD~50~). A 10-fold serial dilution of CFU of *K. pneumoniae* was made and BALB/c mice were injected intraperitonially with 0.1 ml of each concentration. Symptoms and signs of infection were observed for 14 days. Survival of the inoculated mice was recorded and the LD50 was calculated using SigmaPlot version 7.0 from SPSS Inc. (Chicago, IL).

Results
-------

The results obtained were as follows. All strains from different isolation sites were serotype K1 by PCR and had identical profile by PFGE Fig. (**[4](#F4){ref-type="fig"}**). All strains were positive for *rmpA*, *wzy*~KpK1~ and *aerobactin* genes as revealed by PCR using specific primers Fig. (**[5](#F5){ref-type="fig"}**), Fig. (**[6](#F6){ref-type="fig"}**). By using MLST, all strains belonged to ST 23 (allelic profile: GapA: 2, Inf: 1, Mdh: 1, Pgi: 1, Pho: 9, rpoB: 4, TonB: 12).

The LD~50~ of the isolate was \<10^2^ CFU.

DISCUSSION
==========

KLAS is a community-acquired tissue invasive infection endemic in Taiwan, where its incidence has increased in the past 20 years \[[@R15]\]. The syndrome seems to be spreading into other geografic areas, as sporadic cases have been reported in North America and Europe \[[@R3],[@R9],[@R12],[@R16],[@R23],[@R24]\].

It is remarkable that most of the cases of KLAS outside Asia have involved patients of Asian ethnicity including Filipinos \[[@R1],[@R8],[@R24]-[@R26]\]; the reasons for this are not known \[[@R2],[@R23]\]. Our patient was white.

Although half of the cases occur in otherwise healthy people with no underlying hepatobiliary problems, diabetic patients are more susceptible to *K. pneumoniae*infection because poor glycemic control plays an important role in phagocytic resistance against *K. pneumoniae* \[[@R1],[@R5],[@R6],[@R8],[@R12],[@R26]-[@R29]\].

Patients often complain of vague constitutional symptoms, such as fever and fatigue. Only one-half of patients present with more specific clinical clues as right upper quadrant abdominal pain, jaundice and hepatomegaly \[[@R1],[@R24]\]. Our patient only exhibited signs of fever, and had no abdominal complaints. The development of metastatic infection, a rare infectious complication of gram-negative bacteremia affects 10 -- 13% of patients with KLAS \[[@R1],[@R4],[@R6],[@R8],[@R11],[@R13],[@R30],[@R31]\]. Indeed, if defervescence is delayed, a gallium scan is recommended to detect the presence of metastatic infection \[[@R1]\].

Our patient presented a unique septic metastatic complication. Although many distant suppurative lesions have been described, \[[@R15],[@R29]\] abscess of the gastric wall has never been described as a metastatic complication of KLAS Fig. (**[2](#F2){ref-type="fig"}**), Fig. (**[3](#F3){ref-type="fig"}**).

Treatment, including pigtail catheter drainage and antimicrobial therapy for 2--8 weeks, is highly effective \[[@R1],[@R24]\]. Due to the presence of chromosomally mediated SHV-1 ß-lactamase, which inactivates cefazolin in an inoculum-dependent manner, ceftriaxone was prescribed in our patient rather than cefazolin. It has been shown that extended-spectrum cephalosporin, instead of cefazolin optimizes the outcome of KLAS \[[@R8]\].

Multiple virulence characteristics are responsible for the invasiveness of hypermucoviscous *K. pneumoniae* strains. The conspicuous difference between *K. pneumoniae*and the other enterobacteria is the presence of a thick polysaccharide capsule, which helps the bacterium avoid phagocytosis, being its principal virulence factor \[[@R10],[@R11],[@R21],[@R32]\]. According to the capsular polysaccharide, *K. pneumoniae*can be classified into 77 serological K antigen types, distributed across different geographical areas. K1 is the predominant serotype that causes KLAS in Asia \[[@R5],[@R6],[@R33]-[@R35]\]*.*

Hypermucoviscous phenotypes are encapsulated strains of *K. pneumoniae* (mostly K1 and to a lesser extent K2) that produce vasts amounts of extracapsular polysaccharide constituting a mucoviscous web that protects these strains from phagocytosis by neutrophils and from serum killing by complement \[[@R24],[@R30],[@R36]\]. Hypermucoviscous isolates demonstrate increased virulence in mice \[[@R4],[@R10]\], and grow in sticky colonies that form long (\>5 mm) mucous strings when touched with a bacteriological loop (string test) \[[@R9],[@R10],[@R37],[@R38]\] (Fig. (**[1](#F1){ref-type="fig"}**)). This test provides an easy, rapid diagnostic tool and was prominently seen for the *K pneumoniae* isolated from our patient \[[@R8],[@R39]\].

The biochemical nature of the mucoid phenotype may be unrelated to capsular polysaccharide but rather related to extracapsular polysaccharide \[[@R10]\]. A number of chromosomal and plasmid genes have been proposed or suggested to play key roles generation of the hypermucoviscous phenotype \[[@R23]\]. Chromosomal *magA* gene, which encodes a structural outer membrane protein essential for the production of the exopolysaccharide web, is associated with hypermucoviscous phenotype \[[@R14]\]. Further sequencing of *magA* flanking region revealed that *magA* was the serotype K1 allele of the polymerase *wzy*loci in the *cps*operon (i.e., serotype K1 polymerase gene) \[[@R6],[@R11],[@R12],[@R16],[@R32],[@R40],[@R41]\]. Although the *wzy* gene has been proposed to encode an O-polysaccharide polymerase that recognizes and extends the O-antigen polysaccharide-repeating units in the capsular synthesis process \[[@R42]\], recent investigations have shown it is responsible for K- but not O-antigen polymerization \[[@R12]\]. The *cps*gene clusters of serotypes K1, K2, K5, K20, K54, and K57 have different alleles at both *wzy*and *wzx* loci \[[@R6]\]. With the confirmation that *magA* was a K1-antigen--specific polymerase, and in accordance with the bacterial polysaccharide gene nomenclature scheme, it has been proposed that *magA* has to be renamed *wzy~KpK1~*, the capsular polymerase specific to *K. pneumoniae*serotype K1 \[[@R12]\]. So *wzy~KpK1~* is a chromosomal gene located in the *cps*gene cluster for serotype K1 capsular formation, therefore it is restricted to and present in all of the isolates of this serotype, regardless of virulence \[[@R11],[@R12],[@R43],[@R44]\]*.*Although the deletion mutant of the *wzy* gene decreases mucoviscosity \[[@R42]\], this gene should be considered a component of K1 capsule formation rather than an independent specific virulence gene for *K. pneumoniae* strains causing liver abscess \[[@R16],[@R44]\].

Two plasmid encoded virulence genes, *rmpA* and *aerobactin*, are significant correlated with the high virulence of the invasive strains \[[@R17],[@R36],[@R45],[@R46]\]*.* *RmpA*gene was first described by Nassif *et al*. in 1989 \[[@R47]\]. Yu *et al*. demonstrated that *rmpA*-carrying strains were associated with the hypermucoviscous phenotype, as well as with the invasive clinical syndrome \[[@R26],[@R32],[@R48]\]. *RmpA*gene is a transcriptional activator of the *cps*genes and functions as a positive regulator of extracapsular polysaccharide synthesis \[[@R49]\]. Mostover, mutation in *rmpA* lowers in 13%--29% capsule production \[[@R11]\].

Overproduction of extracellular polysaccharide is encoded by the chromosome and positively controlled by *rmpA*located on a plasmid.

The growth of bacteria in host tissues is limited not only by host defense mechanisms but also by its supply of available iron. Many bacteria attempt to secure their supply of iron in the host by secreting high affinity iron chelators called siderophores, like *aerobactin*. *Aerobactin* can increase virulence in mouse lethality tests by 100-fold \[[@R46],[@R50]\]. The *aerobactin* and *rmpA* genes have been identified to be simultaneously located on a 180-kilobase plasmid \[[@R10],[@R17]\], thus, the presence of *rmpA* gene and phenotypic evidence of *aerobactin* production are closely correlated \[[@R10]\].

The *K. pneumoniae* isolate of our patient was a K1 serotype with hypermucoviscous phenotype carrying *rmpA*, *aerobactin* and *wzy~KpK1~* genes. It is noteworthy that K1 serotype is infrequent in clinical isolates from Western countries \[[@R33]\].

Although K serotyping has been the dominant common language for recognition of related *K. pneumoniae* strains in epidemiological and virulence studies, demonstration of clonal dissemination requires genotypic studies. Comparison of isolates by PFGE has several limitations, including different definitions of clonality from different laboratories. MLST is a nucleotide sequence--based typing method that successfully catalogs bacterial pathogens, with complete reproducibility among laboratories, overcoming the limitations of band-based typing methods \[[@R34],[@R51]\]. Isolates with the same K type may belong to unrelated STs. Indeed, most K-types belong to unrelated STs, and the shared K type results from horizontal transfer of the*cps*operon among unrelated genotypes. Therefore, knowledge of the K type provides unreliable prediction of clone identity \[[@R21]\].

It has been shown that K1 serotype *K. pneumoniae*strains responsible for endemic KLAS in Asia, are genetically homogeneous, and belong to ST23 \[[@R34]\], which have been shown to be more virulent in animal lethality studies than other STs. (L. K. Siu, personal communication). Our isolation belonged to ST23, suggesting its global dissemination.

All ST23 clinical strains reported are susceptible to antibiotics commonly used for *Klebsiella* infections \[[@R51]\]. This pattern of susceptibility has remained unchanged. Virulence and resistance are not independent properties; furthermore, genes and environment interact to determine the fitness costs of resistance. The relationship between virulence and resistance may play an important role in the pathogenesis of this invasive infection. It is plausible that the acquisition of resistance may affect the virulence of the bacteria \[[@R1],[@R14]\].

This represents the first reported case of hypermucoviscous serotype K1 *K. pneumoniae*associated with liver abscess and bacteremia in Argentina. These strains can be readily detected by the string test (Fig. (**[1](#F1){ref-type="fig"}**)). MLST and molecular characterization of hypermucoviscous phenotype associated genes is straightforward. Further geographic dissemination of hypermucoviscous K1 *K. pneumoniae* strains of ST23 is likely. Increased awareness about KLAS by physicians and public health officials in South America and worldwide could allow earlier detection and optimal treatment of patients \[[@R26]\]. A rising number of cases from other geographic regions indicate that this is a globally emerging infectious disease.
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![String test result for *Klebsiella pneumoniae.* Stretching of *K. pneumoniae* colonies isolated from our patient's sample resulted in the formation of a string \>5 mm in length, demonstrating the hypermucoviscosity phenotype.](TOMICROJ-5-107_F1){#F1}

![Abdominal Computed Tomography (CT) scan images a) CT showing a 15 cm diameter liver abscess with internal septa and irregular margins.](TOMICROJ-5-107_F2a){#F2a}

![CT hypodensity tumour like lesion with narrowing of the gastric lumen (gastric abscess).](TOMICROJ-5-107_F2b){#F2b}

![Endoscopy showing submucosal mass](TOMICROJ-5-107_F3a){#F3a}

![Endoscopy-ultrasound demonstrating a 3-cm well circumscribed hypoechoic submucosal mass suggestive of intramural abscess.](TOMICROJ-5-107_F3b){#F3b}

![Pulsed-field gel electrophoresis showing identical profile of all the four isolates (2 from blood and 2 from liver abscess) of *K. pneumoniae* from the same patient.](TOMICROJ-5-107_F4){#F4}

![Polymerase chain reaction detection for *wzy~KPK1~* and *rmpA* genes](TOMICROJ-5-107_F5){#F5}

![Positive polymerase chain reaction for *aerobactin.*](TOMICROJ-5-107_F6){#F6}

###### 

Primers Used for Amplification of Target Genes of *K. Pneumoniae*

  Target Gene   Primer                              Size of PCR Product (bp)   Reference
  ------------- ----------------------------------- -------------------------- ------------
  Serotype                                                                     
  K1            5'-GGTGCTCTTTACATCATTGC-3'          1283                       \[[@R18]\]
                5'-GCAATGGCCATTTGCGTTAG-3'                                     
  K2            5'-GACCCGATATTCATACTTGACAGAG-3'     641                        \[[@R18]\]
                5'-CCTGAAGTAAAATCGTAAATAGATGGC-3'                              
  K5            5'-TGGTAGTGATGCTCGCGA-3'            280                        \[[@R18]\]
                5'-CCTGAACCCACCCCAATC-3'                                       
  *RmpA*        5'-ACTGGGCTACCTCTGCTTCA-3'          535                        \[[@R47]\]
                5'-CTTGCATGAGCCATCTTTCA-3'                                     
  Aerobactin    5'-GCATAGGCGGATACGAACAT-3'          556                        \[[@R47]\]
                5'-CACAGGGCAATTGCTTACCT-3'                                     
  Aerobactin    5'-CTGTCGGCATCGGTTTTATT-3'          531                        \[[@R47]\]
                5'-TGGCGTGTCGATTATTACCA-3'                                     
